Activity
-
The Biosimilars Forum is a leading source for innovative thought leadership, educational resources, and biosimilar scientific information, aimed at…
The Biosimilars Forum is a leading source for innovative thought leadership, educational resources, and biosimilar scientific information, aimed at…
Liked by Tom Shea
-
The Biosimilars Forum recently presented the Biosimilars Champion award to five alliance champions for their work and dedication to increasing access…
The Biosimilars Forum recently presented the Biosimilars Champion award to five alliance champions for their work and dedication to increasing access…
Liked by Tom Shea
More activity by Tom
-
Today, we're excited to announce Invenergy’s Center of Excellence, a $30 million clean energy training and manufacturing facility located about 30…
Today, we're excited to announce Invenergy’s Center of Excellence, a $30 million clean energy training and manufacturing facility located about 30…
Liked by Tom Shea
-
Connecting the dots! - terrific and thorough report from IPRP on enabling efficient biosimilar development connects directly to two new IGBA policy…
Connecting the dots! - terrific and thorough report from IPRP on enabling efficient biosimilar development connects directly to two new IGBA policy…
Liked by Tom Shea
-
The Xentria team gathered at our Chicago headquarters this week for our annual summer meeting. It was an incredible week of events, teambuilding…
The Xentria team gathered at our Chicago headquarters this week for our annual summer meeting. It was an incredible week of events, teambuilding…
Liked by Tom Shea
-
I had a fantastic experience in Chicago at Xentria participating in a Patient-Journey Discussion panel. I had the pleasure of meeting some wonderful…
I had a fantastic experience in Chicago at Xentria participating in a Patient-Journey Discussion panel. I had the pleasure of meeting some wonderful…
Liked by Tom Shea
-
This morning, we issued a press release to share updates on our JAG201 program targeting a genetic form of #autism spectrum disorder and…
This morning, we issued a press release to share updates on our JAG201 program targeting a genetic form of #autism spectrum disorder and…
Liked by Tom Shea
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Tom Shea in United States
-
Tom Shea
-
Tom Shea
-
Tom Shea
-
Tom Shea
Global Head of Middle Office at Manulife
-
Tom Shea
Chairman & Founder, Right Management-FL/Carib | Outplacement | Executive Coaching |Talent Management | Career Management
391 others named Tom Shea in United States are on LinkedIn
See others named Tom Shea